Skip to main content
Previous Poster Home Next

Real-world Treatment Patterns of Selumetinib Among Patients with Neurofibromatosis Type I and Plexiform Neurofibroma in the United States
07:30am - 03:35pm EST - April 5, 2024

  • Information
  • Resources

Abstract: JNCCN23-0652 https://jnccn.org/view/journal...


Author(s):
  • Rose Chang, ScD, Merck & Co Inc.

Tags: Outcomes and Health Services Research

Display Label Action